News
Twist Bioscience
TWST · NASDAQ
$142.70+$2.93 (+2.10%)TodayMarket closed ·
Prev close $139.77
Latest news
- NewsAvi Kapoor
Humana, Evolution Metals & Technologies, Fastly And Other Big Stocks Moving Higher On Friday
- NewsChandrima Sanyal
Cathie Wood's $22M Biotech Shuffle, Dumps One Stock for 21st Straight Session While Other Bets Pile Up
- NewsRishabh Mishra
Cathie Wood Claps Back After Being Confronted as ARKK Fell Nearly 15% While QQQ Soared 112% in Five Years — Calls It an ‘Incorrect Comparison’
- Press releasePRNewswire
AI Drug Discovery Forecasts Vary Widely as Sector Shifts to Deployment
- NewsEvette Mitkov
Twist Bioscience Stock Hits New High, Then Retreats: What's Happening?
- NewsVandana Singh
Beyond Hype: Twist Bioscience Secures Data Pipeline Role In Eli Lilly TuneLab Ecosystem
- NewsAvi Kapoor
LuxExperience, Alvotech, Twist Bioscience And Other Big Stocks Moving Higher On Wednesday
- Press releaseBusiness Wire
Twist Bioscience Joins Lilly TuneLab to Advance Antibody Drug Discovery
- Press releaseBusiness Wire
Twist Bioscience to Present at Baird 2026 Global Healthcare Conference
- Press releasePRNewswire
AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030
- NewsHenry Khederian
Twist Bioscience Stock Resilient Despite Scorpion Capital Short Report
- NewsVandana Singh
Twist Bioscience Stock Hits 52-Week High - Here's Why
- Press releaseBusiness Wire
Twist Bioscience Announces Pricing of Upsized $300.0 Million Public Offering of Common Stock
- Press releaseBusiness Wire
Twist Bioscience Announces Proposed Public Offering of $250.0 Million of Common Stock
- Press releaseBusiness Wire
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
- NewsVandana Singh
Twist Bioscience Sees AI Drug Discovery Pipeline Expand
- Press releaseBusiness Wire
Twist Bioscience Announces Fiscal 2026 Third Quarter Financial Results
- Press releaseBusiness Wire
Twist Bioscience to Report Fiscal 2026 Third Quarter Financial Results on Monday, August 3, 2026
- Press releaseBusiness Wire
Twist Bioscience to Present at William Blair 46th Annual Growth Stock Conference
- NewsAvi Kapoor
These Analysts Boost Their Forecasts On Twist Bioscience After Q2 Results
- Press releaseBusiness Wire
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
- NewsVandana Singh
AI-Driven Demand Boosts Twist Bioscience Sales, But Loss Widens
- News
Twist Bioscience Q2 2026 Earnings Call Transcript
- Press releaseBusiness Wire
Twist Bioscience Expands Clonal Genes Offering to Include Long and Complex Sequences
- Press releaseBusiness Wire
Twist Bioscience Announces Fiscal 2026 Second Quarter Financial Results
- News
Earnings Scheduled For May 4, 2026
- Press releaseBusiness Wire
Twist Bioscience to Report Fiscal 2026 Second Quarter Financial Results on Monday, May 4, 2026
- NewsGianni di Poce
The Insider Report: The Two Way Tape Continues as Bears Hold Firm
- NewsErica Kollmann
ARK Unplugged: How Cathie Wood Crushed the S&P 500 in 2025
- Press releaseBusiness Wire
Twist Bioscience to Present at Upcoming Investor Conferences
- Press releaseBusiness Wire
Twist Bioscience Expands Antibody Discovery Offering with Bispecific Licensing Agreement
- Press releaseBusiness Wire
Twist Bioscience Launches Next-Generation Library Preparation Kits Powered by Proprietary Enzymes
- Press releaseBusiness Wire
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
- Press releaseBusiness Wire
Twist Bioscience Announces Fiscal 2026 First Quarter Financial Results
- Press releaseGlobe Newswire
Gene Synthesis Market Size to Surpass USD 9.54 Billion by 2033 | Straits Research
- Press releaseGlobe Newswire
Absci and Twist Bioscience Collaborate to Design Novel Antibody using Generative AI
- Press releaseGlobe Newswire
How A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market Updates
- Press releaseBusiness Wire
Twist Bioscience Announces Clinical Progression of Pure Biologics' Antibody Candidate Discovered Using Twist's Antibody Libraries
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.